Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $202,316 | |
| Profit allocation | Dividend and reserves | |
| Loans and borrowings | $472,072 | |
| Capital expenditure | $387,475 | |
| Planned capital expenditure (next year) | $211,452 | |
| Foreign sales | 0.47% of revenue ($96,248) |
Filing timeliness
1 of 6 financial statements was filed late (for 2025, 44 days late). All were audited by a statutory auditor.
- 202528/08/2026
- 202427/06/2025
- 202307/06/2024
- 202205/07/2023
- 202116/05/2022
- 202014/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Public procurement
No recorded participation in tenders.
Naos Poland is the contractor in one public sector contract, worth USD 92.65.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Aug 18, 2026 | Other cosmetic products | $92.65 | Uniwersytet Medyczny w Lublinie |
Trademarks
Naos Poland holds 1 active trademark registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| Z sercem o atopii | Oct 23, 2027 | |
| ODKRYJ INTELIGENCJĘ SKÓRY(word) | – | |
| Z sercem o atopii | – |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company is represented by two members of the management board, or one member of the management board with a commercial proxy. In the case of a one-person management board, the company is represented independently by the President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Naos Sas | 25,360 | $3,425,175.58 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-11-01.
78 1600 1462 1836 7467 5000 0003
08 1600 1462 1836 7467 5000 0002
40 1600 1462 1836 7467 5000 0008
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 9,460PLN 9,460 |
Secured liabilities
| Type | Creditor | |
|---|---|---|
Pledge | – |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 6, 2020 | Other crisis aid | –– | Prezydent Miasta Kraków |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| LR Health & Beauty Systemssp. z o.o. | $24,626,266.65 | lrworld.com | ||
| Parfum CompanyS.K.A. | $24,194,558.05 | parfumcompany.pl | ||
| Wega Bissp. z o.o. | $14,243,453.82 | wegabis.com | ||
| Sericasp. z o.o. | $13,971,090.93 | e-mamas.com | ||
| Dermoelitesp. z o.o. | $13,213,255.61 | dermomedica.pl | ||
| VIS Plantissp. z o.o. | $9,841,164.25 | visplantis.pl | ||
| Citipharmsp. z o.o. + limited partnership | $1,829,937.74 | citipharm.pl | ||
| Callux Internationalsp. z o.o. | $924,545.41 | callux.pl | ||
| Highlander EnterpriseS.A. | $574,223.07 | highlanderenterprise.com | ||
| Salco Au Naturelsp. z o.o. | $536,005.39 | salcoaunaturel.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-03-19 | Address change (Ul. Dekerta 24, 30-703, Kraków → Ul. Saska 25c, 30-720, Kraków) | |
| 2021-06-16 | Share capital increase (50,000.00 PLN → 12,680,000.00 PLN) | |
| 2015-01-07 | Address change (Golikówka 45, 30-723, Karków → Ul. Dekerta 24, 30-703, Kraków) | |
| 2015-01-07 | Name change (Laboratoire Dermatologique Bioderma Poland → Naos Poland) | |
| 2012-04-04 | Switch to PKD 2007 (8 PKD 2004 codes → 10 PKD 2007 codes) |
FAQ
Last updated: 2026-10-07